MegaRobo Technologies, a Chinese firm that applies robotics and artificial intelligence (AI) in life sciences research, has pocketed $300 million in a Series C round of financing.
Goldman Sachs’ private investment arm, venture capital (VC) company GGV Capital, and Asia Investment Capital led the round, with participation from Sinovation Ventures, Pavilion Capital, and Starr Capital, MegaRobo announced in a statement on Wednesday. China-focused investment companies Yumeng Capital, Redview Capital, and Harvest Capital, as well as investment bank Taihecap also injected capital into the deal.
